By: IPP Bureau
Last updated : August 28, 2025 10:52 am
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64
Samsung, India’s leading consumer electronics brand, in partnership with NeuroLogica, a subsidiary of Samsung Electronics Co., has launched a new portfolio of mobile CT systems designed to redefine diagnostic and interventional radiology in India. These cutting-edge technologies prioritize mobility, AI-driven efficiency, and patient-focused design, aiming to deliver high-quality care in any clinical setting.
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64. Each system is tailored to meet a wide range of clinical needs and can be adopted by hospitals and specialty centers of all sizes, including those in underserved regions. With this launch, Samsung aims to democratize access to advanced imaging across the country.
“At Samsung, we are committed to making advanced medical imaging more accessible and patient-centric,” said Atantra Das Gupta, Head of HME Business at Samsung India. “These mobile CT solutions are designed not only to improve diagnostic capabilities but also to empower healthcare providers across metros and tier-2/3 cities, enhancing clinical outcomes at scale.”
Samsung’s mobile CT systems enable hospitals to bring imaging directly to patients in critical areas such as neuro ICUs, emergency departments, operating rooms, oncology units, and pediatric intensive care. This reduces risk, enhances clinical safety, and supports faster decision-making. Additionally, the technology allows facilities to expand imaging capacity without major infrastructure investments, making it a practical solution for both urban and rural healthcare settings.